Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David D Berg

Showing results (31-40 of 121) with videos related to

Pageof 13
Sort By:
Resuscitation|May 17, 2008
Immediate post-shock chest compressions improve outcome from prolonged ventricular fibrillationRobert A Berg, Ronald W Hilwig, Marc D Berg, et al.
European Heart Journal. Acute Cardiovascular Care|May 2, 2015
Outcomes in patients undergoing percutaneous ventricular assist device implantation for cardiogenic shockDavid D Berg, Devraj Sukul, Molly O'Brien, et al.
Circulation. Heart Failure|February 3, 2021
Efficacy and Safety of Sacubitril/Valsartan in High-Risk Patients in the PIONEER-HF TrialDavid D Berg, Marc D Samsky, Eric J Velazquez, et al.
Journal of the American Heart Association|April 22, 2021
Cardiovascular Biomarkers and Heart Failure Risk in Stable Patients With Atherothrombotic Disease: A Nested Biomarker Study From TRA 2°P-TIMI 50David D Berg, Benjamin L Freedman, Marc P Bonaca, et al.
JACC. Advances|June 13, 2026
Pressure-Adjusted Heart Rate by Echocardiography and Mortality in the Cardiac Intensive Care UnitKirsten M Lipps, Ashley M Darlington, Garima Dahiya, et al.
JACC. Heart Failure|August 18, 2020
Efficacy and Safety of Sacubitril/Valsartan by Dose Level Achieved in the PIONEER-HF TrialDavid D Berg, Eugene Braunwald, Adam D DeVore, et al.
Clinical Cardiology|July 20, 2022
Epidemiology of heart failure hospitalization in patients with stable atherothrombotic disease: Insights from the TRA 2°P-TIMI 50 trialBenjamin L Freedman, David D Berg, Benjamin M Scirica, et al.
Clinical Cardiology|January 24, 2023
Response to Mei et al. regarding the incidence and predictors of hospitalization for heart failure among patients with stable atherosclerosis in the TRA 2°P-TIMI 50 trialBenjamin L Freedman, David D Berg, Benjamin M Scirica, et al.
JACC. Advances|December 25, 2024
Mixed Cardiogenic-Vasodilatory Shock: Current Insights and Future DirectionsJacob C Jentzer, David D Berg, Meshe D Chonde, et al.
Journal of the American College of Cardiology|August 6, 2021
A Targeted Proteomic Approach Identifies Novel Biomarkers of Arterial Thromboembolic Risk in ENGAGE AF-TIMI 48David D Berg, Robert P Giugliano, Christian T Ruff, et al.
Pageof 13

Showing results (31-40 of 121) with videos related to

Sort By:
Pageof 13
Resuscitation|May 17, 2008
Immediate post-shock chest compressions improve outcome from prolonged ventricular fibrillationRobert A Berg, Ronald W Hilwig, Marc D Berg, et al.
European Heart Journal. Acute Cardiovascular Care|May 2, 2015
Outcomes in patients undergoing percutaneous ventricular assist device implantation for cardiogenic shockDavid D Berg, Devraj Sukul, Molly O'Brien, et al.
Circulation. Heart Failure|February 3, 2021
Efficacy and Safety of Sacubitril/Valsartan in High-Risk Patients in the PIONEER-HF TrialDavid D Berg, Marc D Samsky, Eric J Velazquez, et al.
Journal of the American Heart Association|April 22, 2021
Cardiovascular Biomarkers and Heart Failure Risk in Stable Patients With Atherothrombotic Disease: A Nested Biomarker Study From TRA 2°P-TIMI 50David D Berg, Benjamin L Freedman, Marc P Bonaca, et al.
JACC. Advances|June 13, 2026
Pressure-Adjusted Heart Rate by Echocardiography and Mortality in the Cardiac Intensive Care UnitKirsten M Lipps, Ashley M Darlington, Garima Dahiya, et al.
JACC. Heart Failure|August 18, 2020
Efficacy and Safety of Sacubitril/Valsartan by Dose Level Achieved in the PIONEER-HF TrialDavid D Berg, Eugene Braunwald, Adam D DeVore, et al.
Clinical Cardiology|July 20, 2022
Epidemiology of heart failure hospitalization in patients with stable atherothrombotic disease: Insights from the TRA 2°P-TIMI 50 trialBenjamin L Freedman, David D Berg, Benjamin M Scirica, et al.
Clinical Cardiology|January 24, 2023
Response to Mei et al. regarding the incidence and predictors of hospitalization for heart failure among patients with stable atherosclerosis in the TRA 2°P-TIMI 50 trialBenjamin L Freedman, David D Berg, Benjamin M Scirica, et al.
JACC. Advances|December 25, 2024
Mixed Cardiogenic-Vasodilatory Shock: Current Insights and Future DirectionsJacob C Jentzer, David D Berg, Meshe D Chonde, et al.
Journal of the American College of Cardiology|August 6, 2021
A Targeted Proteomic Approach Identifies Novel Biomarkers of Arterial Thromboembolic Risk in ENGAGE AF-TIMI 48David D Berg, Robert P Giugliano, Christian T Ruff, et al.
Pageof 13